Financhill
Sell
9

PTIX Quote, Financials, Valuation and Earnings

Last price:
$3.53
Seasonality move :
1.79%
Day range:
$3.40 - $3.52
52-week range:
$2.35 - $15.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.13x
P/B ratio:
1.61x
Volume:
106K
Avg. volume:
188.9K
1-year change:
-65.77%
Market cap:
$2M
Revenue:
--
EPS (TTM):
-$13.11

Earnings Data

Next earnings date for PTIX
Aug 14
2025
Most recent earnings per share
-$2.75
Missed by $2.75
(May 13/2025)
Consensus Estimate
--
(May 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PTIX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/13/2025 Q1 -- -- -$2.75 -- --
12/31/2024 Q4 -- -- -$3.36 -- --
11/14/2024 Q3 -- -- -$1.96 -- --
08/14/2024 Q2 -- -- -$5.04 -- --
05/15/2024 Q1 -- -- -$5.44 -- --
12/31/2023 Q4 -- -- -$5.32 -- --
11/14/2023 Q3 -- -- -$4.48 -- --
06/30/2023 Q2 -- -- -$3.92 -- --
03/31/2023 Q1 -- -- -$2.38 -- --
12/31/2022 Q4 -- -- -$1.96 -- --
09/30/2022 Q3 -- -- -$2.94 -- --
08/16/2022 Q2 -- -- -$2.10 -- --
03/31/2022 Q1 -- -- -$4.48 -- --
02/15/2022 Q4 -- -- -$2.80 -$2.80 --
11/15/2021 Q3 -- -- -$2.80 -$4.48 $1.68
08/16/2021 Q2 -- -- -$6.16 -- --
05/17/2021 Q1 -- -- -$6.16 -- --
12/31/2020 Q4 -- -- -$2.80 -- --
09/30/2020 Q3 -- -- -$5.60 -- --
06/30/2020 Q2 -- -- -$3.36 -- --
03/31/2020 Q1 -- -- -$2.80 -- --
12/31/2019 Q4 -- -- -$3.92 -- --
09/30/2019 Q3 -- -- -$0.56 -- --
06/30/2019 Q2 -- -- -$1.68 -- --
03/31/2019 Q1 -- -- -$3.36 -- --
12/31/2018 Q4 -- -- -$4.48 -- --
09/30/2018 Q3 -- -- -$2.80 -- --
06/30/2018 Q2 -- -- -$3.92 -- --
03/31/2018 Q1 -- -- -$3.36 -- --
12/31/2017 Q4 -- -- -$3.92 -- --
09/30/2017 Q3 -- -- -$2.24 -- --
06/30/2017 Q2 -- -- -$2.24 -- --
03/31/2017 Q1 -- -- -$3.36 -- --
12/31/2016 Q4 -- -- -$3.04 -- --
09/30/2016 Q3 -- -- -$3.36 -- --
06/30/2016 Q2 -- -- -$4.48 -- --
03/31/2016 Q1 -- -- -$1,594.36 -- --
12/31/2015 Q4 -- -- -$340.52 -- --
09/30/2015 Q3 -- -- -$282.33 -- --

Protagenic Therapeutics Earnings Questions

  • How Much did Protagenic Therapeutics Generate in Revenue Last Quarter?

    Protagenic Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Protagenic Therapeutics Beat Earnings Last Quarter?

    Protagenic Therapeutics announced earnings per share of -$2.75 which represents a miss of analyst forecast a -- per share.

  • Is Protagenic Therapeutics Profitable?

    Protagenic Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Protagenic Therapeutics EPS Next Year?

    Protagenic Therapeutics's earnings are forecast to grow from -$15.82 per share to -- per share next year representing an increase of --.

  • When is Protagenic Therapeutics's Earnings Date?

    Protagenic Therapeutics's next earnings date is August 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 58x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
82
SBET alert for Jul 17

SharpLink Gaming [SBET] is down 2.6% over the past day.

Buy
89
EXOD alert for Jul 17

Exodus Movement [EXOD] is down 4.14% over the past day.

Buy
60
U alert for Jul 17

Unity Software [U] is up 7.51% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock